FAM
FSTX

Formidable Asset Management’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Formidable Asset Management’s Portfolio FSTX Stock Details FSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-55,366
Closed -$350K – 340
2022
Q4 		$350K Sell
55,366
-7,112
-11% -$39.4K 0.08% 213
2022
Q3 		$320K Buy
62,478
+1,388
+2% +$8.72K 0.07% 210
2022
Q2 		$382K Buy
+61,090
New +$206K 0.09% 202

Formidable Asset Management's FSTX Position: Q1 2023 in Review

Formidable Asset Management sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q1 2023, closing a stake of 55,366 shares — an estimated $350K sold.

Formidable Asset Management first reported a position in FSTX in Q2 2022 and held it in 3 quarters. The position peaked at $382K in Q2 2022. 0 funds tracked by Wall St. Rank hold FSTX as of Q1 2023.

  • Formidable Asset Management reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Formidable Asset Management sold 55,366 F-star Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $350K.
  • Formidable Asset Management first reported a position in F-star Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Formidable Asset Management's F-star Therapeutics, Inc. Common Stock position peaked at $382K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Formidable Asset Management's 13F filing for Q1 2023, filed 9 May 2023.